Publications by authors named "Cathy Tangen"

Claim this Profile
C
Considerations for the Next Clinical Trial Evaluating the Role of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma.
Hyung L Kim, Eddie Mayerson, Primo N Lara, Edward Messing, Cathy Tangen

Eur Urol Focus· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer Risk.
Ruth C Travis, Aurora Perez-Cornago, Paul N Appleby, Demetrius Albanes, Corinne E Joshu, Cathy M Tangen

Cancer Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Background and Update for S1602 "A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-naïve High-grade Non-muscle-invasive Bladder Cancer.
Robert S Svatek, Cathy Tangen, Scott Delacroix, William Lowrance, Seth P Lerner

Eur Urol Focus· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SWOG S0353: Phase II trial of intravesical gemcitabine in patients with nonmuscle invasive bladder cancer and recurrence after 2 prior courses of intravesical bacillus Calmette-Guérin.
Eila C Skinner, Bryan Goldman, Wael A Sakr, Daniel P Petrylak, Heinz-Josef Lenz, Cathy M Tangen

J Urol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II evaluation of early oral estramustine, oral etoposide, and intravenous paclitaxel combined with hormonal therapy in patients with high-risk metastatic prostate adenocarcinoma: Southwest Oncology Group S0032.
David C Smith, Cathy M Tangen, Peter J Van Veldhuizen, Grant W Harrer, Ali Golshayan

Urology· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum oxidized protein and prostate cancer risk within the Prostate Cancer Prevention Trial.
Ashraful Hoque, Christine B Ambrosone, Cathee Till, Phyllis J Goodman, Cathy Tangen

Cancer Prev Res (Phila)· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A sequential treatment approach to myoinvasive urothelial cancer: a phase II Southwest Oncology Group trial (S0219).
Ralph W deVere White, Primo N Lara, Bryan Goldman, Cathy M Tangen, David C Smith

J Urol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate-specific antigen progression predicts overall survival in patients with metastatic prostate cancer: data from Southwest Oncology Group Trials 9346 (Intergroup Study 0162) and 9916.
Maha Hussain, Bryan Goldman, Cathy Tangen, Celestia S Higano, Daniel P Petrylak

J Clin Oncol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COOPERATIVE GROUP TRIALS - SOUTHWEST ONCOLOGY GROUP (SWOG) INNOVATIONS IN ADVANCED PROSTATE CANCER.
Tanya B Dorff, Cathy M Tangen, E David Crawford, Daniel P Petrylak, Celestia S Higano

Ther Adv Med Oncol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting prostate cancer risk through incorporation of prostate cancer gene 3.
Donna Pauler Ankerst, Jack Groskopf, John R Day, Amy Blase, Harry Rittenhouse, Cathy Tangen

J Urol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aneusomy for detection of bladder cancer recurrence: a Southwest Oncology Group study.
Sandra R Wolman, Bryan Goldman, Marilyn L Slovak, Cathy Tangen, Diane L Persons

Cancer Genet Cytogenet· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone mineral density in patients with prostate cancer without bone metastases treated with intermittent androgen suppression.
Celestia Higano, Andrew Shields, Nathanael Wood, Judy Brown, Cathy Tangen

Urology· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis.
Robert C Flanigan, G Mickisch, Richard Sylvester, Cathy Tangen, H Van Poppel

J Urol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis